Helen Rothlein of Morgan Stanley Under Investigation for Covered Options Trades

Financial Advisor Lost My Money

Haselkorn & Thibaut, a national investment fraud law firm with over 50 years of experience, has initiated an investigation into Helen Rothlein (CRD #709040), currently registered with Morgan Stanley in New York, NY.

If you are a current or former client of Helen Rothlein, or if you have concerns about your investments with Morgan Stanley, this in-depth report highlights the advisor’s regulatory background, outlines reported red flags, and provides you with proactive next steps. Your financial well-being is our priority, and we are here to help answer your questions with a free, confidential consultation at 1-888-994-8066.

Executive Summary of Helen Rothlein’s Background

  • Name: Helen Rothlein
  • CRD Number: 709040
  • Current Broker-Dealer: Morgan Stanley (New York, NY)
  • Employment Dates: Morgan Stanley (2009–Present); Citigroup Global Markets Inc (1981–2009)
  • Licenses: Series 63, 65, 66 (all active since 2009)
  • Registration Status: Active

Public regulatory records indicate one customer complaint and no regulatory actions or SEC disciplinary events as of the latest review. The presence of a customer complaint signals the importance of due diligence and open communication when working with any advisor.

Investor Risk Assessment

Risk Level: Yellow (Caution Advised)
A “yellow” risk level signifies that, while there is no high-severity disciplinary action, the presence of a formal complaint should prompt heightened awareness and clarifying questions for prospective or current clients.
  • Ask direct questions about the complaint and any lessons learned.
  • Regularly review statements, confirm understanding of fees & risks.
  • Seek independent professional advice if any concerns arise.

Complete List of Disclosed Complaints for Helen Rothlein

Type Date Filed Details Resolution
Customer Complaint March 1, 2025 Allegations: It is alleged that Helen Rothlein recommended unsuitable covered options trades between 2019 and 2023, causing damages of $429,000.
Product(s) in Question: Covered Options Trades
Pending

This is the only complaint disclosed on regulatory records for Helen Rothlein at this time. The allegation remains unresolved and under review. Investors are encouraged to watch this space for potential updates and discuss any worries directly with a qualified representative.

In-Depth Analysis: Helen Rothlein’s Risk Profile

  • Regulatory Disclosures: 1 customer complaint, no regulatory actions (Low Severity)
  • Product Risk: No recurring high-risk product issues identified
  • Pattern Analysis: No evidence of concerning patterns or multiple complaints
  • SEC/FINRA Background: No findings of liability, sanctions, or major regulatory infractions
  • Public Reputation: 2 FINRA arbitration awards found, but not all necessarily related to Rothlein’s own conduct
  • Employment Profile: Long-term, established advisor history at major broker-dealers

No disciplinary actions from regulators or the SEC have been recorded against Helen Rothlein. However, the open complaint is a crucial detail, particularly for those with similar account characteristics or investment strategies.

What Investors Should Do Next

  • Review your Morgan Stanley account statements for unfamiliar transactions—especially concerning options trades or strategies you did not fully understand.
  • Document all communications with your advisor, keeping track of guidance received and explanations provided about product risks or suitability.
  • Ask for written explanations regarding any strategies or products that resulted in losses.
  • Understand that you do not have to accept unresolved uncertainty—consulting an expert can protect your interests.

For your own account, consider asking Helen Rothlein these clarification questions:

  • Can you explain the circumstances surrounding the complaint(s) on your record?
  • What was the resolution, and were any settlements or awards made?

How Haselkorn & Thibaut Can Help You

  • No recovery, no fee policy.
  • Former investment professionals reviewing every consultation.
  • 98% success rate with millions recovered for investors nationwide.
  • Complimentary, zero-obligation case evaluations for investors wondering if their losses are recoverable.

The firm is not associated with Morgan Stanley or Helen Rothlein. All information considered is based on official regulatory records and reported customer claims as of the latest review.

Scroll to Top